Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Jahn

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Blood|January 10, 2023
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signaturesBenjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan, et al.
Science (New York, N.Y.)|February 1, 2024
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127Skye Montoya, Jessie Bourcier, Mark Noviski, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Blood|January 10, 2023
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signaturesBenjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan, et al.
Science (New York, N.Y.)|February 1, 2024
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127Skye Montoya, Jessie Bourcier, Mark Noviski, et al.
Pageof 3